<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="57" height="12" font="1">June 28, 2011</text>
<text top="353" left="94" width="426" height="12" font="1">Anti-ELK4 (H-167) is a rabbit polyclonal antibody raised against amino acids 154-320 of ELK4 of human </text>
<text top="365" left="94" width="27" height="12" font="1">origin.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="66" height="12" font="1">frietze@usc.edu</text>
<text top="134" left="83" width="49" height="12" font="1">Seth Frietze</text>
<text top="215" left="121" width="72" height="12" font="1">anti-ELK4 (H-167)</text>
<text top="215" left="339" width="20" height="12" font="1">ELK4</text>
<text top="170" left="230" width="37" height="12" font="1">Farnham</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="25" height="12" font="1">E0603</text>
<text top="300" left="215" width="37" height="12" font="1">sc-13030</text>
<text top="521" left="395" width="19" height="12" font="2">ChIP</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="638" left="103" width="205" height="12" font="2">http://www.ncbi.nlm.nih.gov/pubmed/21126370</text>
<text top="425" left="94" width="425" height="12" font="1">This gene is a member of the Ets family of transcription factors and of the ternary complex factor (TCF) </text>
<text top="437" left="94" width="43" height="12" font="1">subfamily.</text>
<text top="599" left="238" width="169" height="12" font="1">http://datasheets.scbt.com/sc-13030.pdf</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="134" left="125" width="409" height="12" font="1">ELK4 Western blotting. Nuclear extracts were prepared from Hela and HEK293 cells and 25ug were </text>
<text top="146" left="125" width="427" height="12" font="1">loaded onto an 10% SDS-PAGE for Western blotting using anti-ELK4 antibody at a dilution of 1:1,000. A </text>
<text top="158" left="125" width="422" height="12" font="1">specific band corresponding to the predicted molecular weight (approximately 47 kDa) was detected </text>
<text top="170" left="125" width="201" height="12" font="1">and no other non-specific bands were observed.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="123" left="130" width="424" height="12" font="1">ChIP-seq was performed using a ELK4 antibody in Hela cells. The top 1000 peaks were analyzed with a </text>
<text top="135" left="130" width="386" height="12" font="1">de novo motif analysis (http://motif.bmi.ohio-state.edu/ChIPMotifs/).  The top motif that was </text>
<text top="147" left="130" width="390" height="12" font="1">identified was CTTCCGG (P value: 1.0215e-318), which in the reverse direction is CCGGAAG.  A </text>
<text top="159" left="130" width="409" height="12" font="1">previously identified motif for ELK4 is ACTTCCGGT (EMBO J. 2010 July 7; 29(13): 2147â€“2160), which </text>
<text top="171" left="130" width="403" height="12" font="1">contains the same core sequence as the de novo motif identified for ELK4.  We then analyzed the </text>
<text top="183" left="130" width="406" height="12" font="1">percentage of peaks containing the de novo ELK4 motif in the entire set of ELK4 called peaks.  We </text>
<text top="195" left="130" width="418" height="12" font="1">found that 88% of the top 1000 peaks  contained this motif, with the percentage dropping to 75% in </text>
<text top="207" left="130" width="135" height="12" font="1">the top 3715 peaks the dataset.  </text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
